Your browser doesn't support javascript.
loading
Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001.
McCoach, Caroline E; Rolfo, Christian; Drilon, Alexander; Lacouture, Mario; Besse, Benjamin; Goto, Koichi; Zhu, Viola W; Tan, Daniel S W; Farajian, Stephanie; Potter, Laura A; Kherani, Jennifer F; Soldatenkova, Victoria; Olek, Elizabeth A; Muehlenbein, Catherine E; Park, Keunchil.
Afiliação
  • McCoach CE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Present Address: Genentech, Inc., South San Francisco, California. Electronic address: caroline.mccoach@ucsf.edu.
  • Rolfo C; Greenebaum Comprehensive Cancer Center, Experimental Therapeutics Program, School of Medicine, University of Maryland, Baltimore, Maryland; Present Address: Center for Thoracic Oncology at Tisch Cancer Institute, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New Yo
  • Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
  • Lacouture M; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
  • Besse B; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Zhu VW; Department of Medicine, Division of Hematology and Oncology, University of California Irvine, Orange, California.
  • Tan DSW; National Cancer Centre Singapore, Duke-National University of Singapore Medical School, Singapore.
  • Farajian S; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Potter LA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Present Address: Davis School of Medicine, University of California, Sacramento, Sacramento, California.
  • Kherani JF; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut.
  • Soldatenkova V; Eli Lilly and Company, Indianapolis, Indiana.
  • Olek EA; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut.
  • Muehlenbein CE; Eli Lilly and Company, Indianapolis, Indiana.
  • Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
J Thorac Oncol ; 17(6): 768-778, 2022 06.
Article em En | MEDLINE | ID: mdl-35183775
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2022 Tipo de documento: Article